Bavarian: Of course we would like to supply Denmark
Danish authorities have once again stalled on a decision on whether or not to buy Bavarian Nordic’s small pox vaccine. But Bavarian would be happy to deliver to its home country, the company’s CFO says.
BY STEFAN SINGH KAILAY & BENJAMIN WERNER CHRISTENSEN
Although Bavarian Nordic’s small pox vaccine Imvanex is not set to be included in the Danish bio-defense system just yet, the Denmark-based biotech’s finance chief remains calm.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
Med din prøveperiode får du:
Få fuld adgang til dig og dine kollegaer
Start et gratis virksomhedsprøveabonnementRelaterede artikler
Aamund: We have reached the pearly gates
For abonnenter
”You won’t hear from us until we have struck a deal”
For abonnenter
Bavarian: We are preparing for the next step
For abonnenter
